209 related articles for article (PubMed ID: 21910722)
1. Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease.
Horváth R; Rožková D; Lašťovička J; Poloučková A; Sedláček P; Sedivá A; Spíšek R
Clin Exp Immunol; 2011 Oct; 166(1):26-33. PubMed ID: 21910722
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.
Ma CS; Chew GY; Simpson N; Priyadarshi A; Wong M; Grimbacher B; Fulcher DA; Tangye SG; Cook MC
J Exp Med; 2008 Jul; 205(7):1551-7. PubMed ID: 18591410
[TBL] [Abstract][Full Text] [Related]
3. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.
Ifrim DC; Quintin J; Meerstein-Kessel L; Plantinga TS; Joosten LA; van der Meer JW; van de Veerdonk FL; Netea MG
Clin Exp Immunol; 2015 Sep; 181(3):434-40. PubMed ID: 25880788
[TBL] [Abstract][Full Text] [Related]
4. Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: role in T helper development.
Shatynski KE; Chen H; Kwon J; Williams MS
Eur J Immunol; 2012 Dec; 42(12):3202-11. PubMed ID: 22930452
[TBL] [Abstract][Full Text] [Related]
5. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
[TBL] [Abstract][Full Text] [Related]
6. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
7. Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency.
van de Veerdonk FL; Marijnissen RJ; Joosten LA; Kullberg BJ; Drenth JP; Netea MG; van der Meer JW
Clin Exp Immunol; 2010 Jan; 159(1):57-64. PubMed ID: 19878510
[TBL] [Abstract][Full Text] [Related]
8. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
Patel NC; Gallagher JL; Torgerson TR; Gilman AL
J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
[TBL] [Abstract][Full Text] [Related]
9. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
10. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
[TBL] [Abstract][Full Text] [Related]
11.
Park B; Liu GY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
[TBL] [Abstract][Full Text] [Related]
12. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.
Sundin M; Tesi B; Sund Böhme M; Bryceson YT; Pütsep K; Chiang SC; Thunberg S; Winiarski J; Wikström AC
J Clin Immunol; 2014 May; 34(4):469-77. PubMed ID: 24627079
[TBL] [Abstract][Full Text] [Related]
13. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis.
Abusleme L; Diaz PI; Freeman AF; Greenwell-Wild T; Brenchley L; Desai JV; Ng WI; Holland SM; Lionakis MS; Segre JA; Kong HH; Moutsopoulos NM
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185668
[TBL] [Abstract][Full Text] [Related]
14. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells.
Saito M; Nagasawa M; Takada H; Hara T; Tsuchiya S; Agematsu K; Yamada M; Kawamura N; Ariga T; Tsuge I; Nonoyama S; Karasuyama H; Minegishi Y
J Exp Med; 2011 Feb; 208(2):235-49. PubMed ID: 21300911
[TBL] [Abstract][Full Text] [Related]
15. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome.
Minegishi Y; Saito M; Nagasawa M; Takada H; Hara T; Tsuchiya S; Agematsu K; Yamada M; Kawamura N; Ariga T; Tsuge I; Karasuyama H
J Exp Med; 2009 Jun; 206(6):1291-301. PubMed ID: 19487419
[TBL] [Abstract][Full Text] [Related]
16. Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.
Ohga S; Nomura A; Ihara K; Takahata Y; Suga N; Akeda H; Shibata R; Okamura J; Kinukawa N; Hara T
Br J Haematol; 2003 Apr; 121(2):324-31. PubMed ID: 12694256
[TBL] [Abstract][Full Text] [Related]
17. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
[TBL] [Abstract][Full Text] [Related]
18. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.
Béziat V; Li J; Lin JX; Ma CS; Li P; Bousfiha A; Pellier I; Zoghi S; Baris S; Keles S; Gray P; Du N; Wang Y; Zerbib Y; Lévy R; Leclercq T; About F; Lim AI; Rao G; Payne K; Pelham SJ; Avery DT; Deenick EK; Pillay B; Chou J; Guery R; Belkadi A; Guérin A; Migaud M; Rattina V; Ailal F; Benhsaien I; Bouaziz M; Habib T; Chaussabel D; Marr N; El-Benna J; Grimbacher B; Wargon O; Bustamante J; Boisson B; Müller-Fleckenstein I; Fleckenstein B; Chandesris MO; Titeux M; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Meyts I; Di Santo JP; Hovnanian A; Somer A; Ozen A; Rezaei N; Chatila TA; Abel L; Leonard WJ; Tangye SG; Puel A; Casanova JL
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29907691
[TBL] [Abstract][Full Text] [Related]
19. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
